Print ISSN:-2582-6301

Online ISSN:-2582-628X

Current Issue

Year 2020

Volume: 3 , Issue: 2

Article Access statistics

Viewed: 260

Emailed: 0

PDF Downloaded: 109

IP Journal of Nutrition, Metabolism and Health Science


Pde-5 inhibitors: are they enough for erectile dysfunction?


Full Text PDF Share on Facebook Share on Twitter


Review Article

Author Details : Piyush desai*

Volume : 2, Issue : 4, Year : 2019

Article Page : 100-103


Suggest article by email

Abstract

Erectile dysfunction is a part of broader sexual dysfunction which also includes decreases libido and premature ejaculation. The Massachusetts Male Aging Study (MMAS) found that 52% of men between 40 and 70 years old reported having some form of Erectile Dysfunction (ED).1 Medical conditions, such as hypertension, diabetes mellitus, and Cardiovascular Disease (CVD), and psychological conditions, such as depression and anxiety, also contribute to sexual dysfunction in middle-aged elderly men. Neurological disorders such as cerebral diseases, spinal cord injuries and peripheral neuropathies contribute to the ED in some patients. Hormonal disorders such as hypogonadism, vascular disorders such as atherosclerosis and peripheral vascular diseases also causes ED. Drugs implicated as a cause of ED include hydrochlorothiazides and beta-blocking agents

 

Keywords: Administered in the context of an IRB-approved experimental clinical research protocol.

Doi : 10.18231/j.ijnmhs.2019.020

How to cite : Desai P, Pde-5 inhibitors: are they enough for erectile dysfunction?. J Nutr Metab Health Sci 2019;2(4):100-103

Copyright © 2019 by author(s) and J Nutr Metab Health Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)